Polyclonal rabbit antibodies against SHV-1 and CMY-2 -lactamases were produced and characterized, and enzyme-linked immunosorbent assays (ELISAs) were developed. Immunoblots revealed that the anti-SHV-1 antibody recognized SHV-1 but did not recognize TEM-1, K-1, OXA-1, or any AmpC -lactamase tested. The anti-CMY-2 antibody detected Escherichia coli CMY-2, Enterobacter cloacae P99, Klebsiella pneumoniae ACT-1, and the AmpC -lactamases of Enterobacter aerogenes, Morganella morganii, and Citrobacter freundii. No cross-reactivity of the anti-CMY-2 antibody was seen against laboratory strains of E. coli possessing TEM-1, SHV-1, K-1, or OXA-1 -lactamases. Operating conditions for performing ELISAs were optimized. Both anti-CMY-2 and anti-SHV-1 antibodies detected picogram quantities of purified protein in ELISAs. The reactivity of the anti-CMY-2 antibody was tested against a number of AmpC -lactamases by assaying known quantities of purified enzymes in ELISAs (AmpC -lactamases of M. morganii, C. freundii, E. coli, and E. cloacae). As the homology to CMY-2 -lactamase decreased, the minimum level needed for detection increased (e.g., 94% homology recognized at 1 ng/ml and 71% homology recognized at 10 ng/ml). The ELISAs were used to assay unknown clinical isolates for AmpC and SHV -lactamases, and the results were confirmed with PCR amplification of bla AmpC and bla SHV genes. Overall, we found that our ELISAs were at least 95% sensitive and specific for detecting SHV and AmpC -lactamases. The ELISA format can facilitate the identification of AmpC and SHV -lactamases and can be used to quantify relative amounts of -lactamase enzymes in clinical and laboratory isolates.Common molecular techniques available for identifying -lactamases in clinical samples include DNA hybridization (Southern blotting), amplification by PCR with specific primers, and analytical isoelectric focusing (aIEF) (29). For most applications, DNA hybridization with digoxigenin-labeled probes that allow recognition of sequences with less homology (conditions of low stringency) is adequate but can be laborintensive and time-consuming. aIEF is a very sensitive technique that can be performed rapidly (26). Unfortunately, aIEF can be imprecise in determining the identities of -lactamases with pIs of greater than 7.6. PCR-based methods of detection require the construction of specific primers that may not be able to amplify closely related -lactamase genes. Even when multiple PCR primer sets and susceptibility tests are used to identify -lactamases, samples can remain uncharacterized (32).Immunological methods have long been applied to the analysis and classification of -lactamases (4, 5, 7-9, 11, 13, 17, 18, 22-24, 31, 33, 34). Antibody-based methods offer an advantage in that they are easily performed and highly sensitive. Polyclonal antibodies recognize multiple epitopes and can detect closely related variants of -lactamases. Hence, polyclonal antibodies were used early on to classify -lactamases and understand catalysis (33).Most rec...